Join Fund Library now and get free access to personalized features to help you manage your investments.
Sector Equity
Click for more information on Fundata’s ESG Grade
Click for more information on Fundata’s ESG Grade.
|
Close (06-27-2024) |
$11.41 |
|---|---|
| Change |
$0.00
(0.00%)
|
| Open | - |
|---|---|
| Day Range | - - - |
| Volume | 0 |
As at October 31, 2024
As at October 31, 2024
As at July 31, 2024
Loading...
Loading...
Inception Return (November 07, 2022): -16.82%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | -6.72% | -12.60% | 1.34% | -25.16% | 1.29% | - | - | - | - | - | - | - | - | - |
| Benchmark | 0.85% | 5.30% | 12.95% | 18.24% | 32.06% | 15.16% | 8.05% | 15.02% | 11.33% | 11.65% | 9.36% | 9.62% | 9.96% | 8.41% |
| Category Average | -0.55% | 9.75% | 9.75% | 16.69% | 32.21% | 20.51% | 3.93% | 10.09% | 11.90% | 11.88% | 11.02% | 12.06% | 11.03% | 11.60% |
| Category Rank | 196 / 200 | 192 / 195 | 167 / 191 | 185 / 189 | 178 / 189 | - | - | - | - | - | - | - | - | - |
| Quartile Ranking | 4 | 4 | 4 | 4 | 4 | - | - | - | - | - | - | - | - | - |
| Return % | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 17.51% | 15.18% | -11.73% | 11.41% | -8.79% | -17.67% | 4.46% | -3.55% | 15.08% | -3.93% | -2.47% | -6.72% |
| Benchmark | 7.48% | 3.91% | 0.55% | 1.82% | 4.14% | -1.82% | 2.77% | -1.42% | 5.87% | 1.22% | 3.15% | 0.85% |
17.51% (November 2023)
-17.67% (April 2024)
| Return % | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | - | - | - | - | - | - | - | - | - | 13.14% |
| Benchmark | 10.55% | -8.32% | 21.08% | 9.10% | -8.89% | 22.88% | 5.60% | 25.09% | -5.84% | 11.75% |
| Category Average | 17.30% | 16.21% | -0.43% | 20.39% | 1.55% | 22.37% | 29.99% | 15.34% | -25.24% | 26.53% |
| Quartile Ranking | - | - | - | - | - | - | - | - | - | 3 |
| Category Rank | - | - | - | - | - | - | - | - | - | 87/ 161 |
13.14% (2023)
13.14% (2023)
| Name | Percent |
|---|---|
| US Equity | 88.46 |
| International Equity | 7.43 |
| Cash and Equivalents | 3.45 |
| Canadian Equity | 0.66 |
| Name | Percent |
|---|---|
| Healthcare | 88.94 |
| Technology | 3.87 |
| Cash and Cash Equivalent | 3.45 |
| Industrial Goods | 0.78 |
| Other | 2.96 |
| Name | Percent |
|---|---|
| North America | 92.58 |
| Europe | 7.43 |
| Other | -0.01 |
| Name | Percent |
|---|---|
| Twist Bioscience Corp | 7.97 |
| CRISPR Therapeutics AG | 6.68 |
| Recursion Pharmaceuticals Inc Cl A | 6.63 |
| CareDx Inc | 5.14 |
| Adaptive Biotechnologies Corp | 4.41 |
| Veracyte Inc | 4.36 |
| Ionis Pharmaceuticals Inc | 4.18 |
| Nurix Therapeutics Inc | 4.02 |
| 10X Genomics Inc | 3.66 |
| Intellia Therapeutics Inc | 3.57 |
| Standard Deviation | - | - | - |
|---|---|---|---|
| Beta | - | - | - |
| Alpha | - | - | - |
| Rsquared | - | - | - |
| Sharpe | - | - | - |
| Sortino | - | - | - |
| Treynor | - | - | - |
| Tax Efficiency | - | - | - |
| Volatility | - | - | - |
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 40.65% | - | - | - |
| Beta | 3.19% | - | - | - |
| Alpha | -0.82% | - | - | - |
| Rsquared | 0.56% | - | - | - |
| Sharpe | 0.10% | - | - | - |
| Sortino | 0.23% | - | - | - |
| Treynor | 0.01% | - | - | - |
| Tax Efficiency | - | - | - | - |
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
| Start Date | November 07, 2022 |
|---|---|
| Instrument Type | Exchange Traded Fund |
| Share Class | Do-It-Yourself |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Annual |
| Assets ($mil) | $6 |
| 52 Week High | - |
| 52 Week Low | - |
| Annual Dividend | - |
| Annual Yield | - |
| Index | - |
| Shares Outstanding | - |
| Registered Plan Eligible | Yes |
| Exposure | - |
|---|---|
| Asset Class High | - |
| Asset Class Medium | - |
| Asset Class Low | - |
| Leveraged | - |
| Inverse | - |
| Advisor Series | - |
| Covered Call Strategy | No |
This fund’s objective is to provide long-term capital growth by investing primarily in equity securities of companies involved in disruptive genomic innovation from around the world.
These are the strategies the portfolio manager uses to try to achieve the fund’s objectives: invests primarily in global equity securities of companies across various sectors that are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business.
| Name | Start Date |
|---|---|
| Dan White | 05-24-2024 |
| Nicholas Grous | 05-24-2024 |
| Catherine D. Wood | 05-24-2024 |
| Fund Manager | BMO Investments Inc. |
|---|---|
| Advisor | Ark Investment Management LLC |
| Custodian | - |
| Registrar | - |
| Distributor | - |
| Auditor | - |
| MER | 0.84% |
|---|---|
| Management Fee | 0.75% |
Join Fund Library now and get free access to personalized features to help you manage your investments.
Fund Library
